Full audited accounts should tell more. Seems that further dilution is already embedded given most of the deferred consideration is payable in both shares and cash.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025